Sindhu Subramanian*
Assistant Professor, Department of Chemical Engineering and Materials Science, Amrita School of Engineering, Coimbatore, Amrita Vishwa Vidyapeetham, India
*Corresponding Author: Sindhu Subramanian, Assistant Professor, Department of Chemical Engineering and Materials Science, Amrita School of Engineering, Coimbatore, Amrita Vishwa Vidyapeetham, India.
Received: March 26, 2020; Published: May 20, 2020
Elevated blood pressure significantly increases the risks of non-communicable diseases such as cardiovascular, nervous and renal related problem. 1.13 billion people worldwide are estimated to have hypertension in which two-thirds were living in under-developing and developing countries. One of the global targets mentioned by WHO is to reduce the prevalence of hypertension by 25% before 2025. Various antihypertensive agents such as Calcium channel blockers, thiazide diuretics, angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) and ß-blockers are used to treat hypertension. Among these, Calcium channel blockers have shown best effect to reduce hypertension compared to the other recommended agents.
Citation: Sindhu Subramanian. “Nanoparticle based Drug Delivery Systems for the Controlled Release of Antihypertensive Drugs". Acta Scientific Pharmacology 1.6 (2020): 01.
Copyright: © 2020 Sindhu Subramanian. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
+91 9182824667
Open Access by
Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com
ff
